These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6269372

  • 1. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
    Purtilo DT.
    Adv Cancer Res; 1981; 34():279-312. PubMed ID: 6269372
    [No Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT, Tatsumi E, Manolov G, Manolova Y, Harada S, Lipscomb H, Krueger G.
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunopathology of the X-linked lymphoproliferative syndrome.
    Purtilo DT.
    Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M, Benninger-Döring G, Prang N, Sylla BS, Laumbacher B, Wank R, Wolf H, Schwarzmann F.
    Int J Cancer; 1998 May 29; 76(5):694-701. PubMed ID: 9610728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U, Weiss M, Belohradsky BH.
    Monatsschr Kinderheilkd; 1993 Mar 29; 141(3):201-6. PubMed ID: 8386321
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression.
    Purtilo DT, Sakamoto K.
    Hum Pathol; 1981 Aug 29; 12(8):677-9. PubMed ID: 6269987
    [No Abstract] [Full Text] [Related]

  • 14. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections.
    Purtilo DT.
    Pathol Annu; 1980 Aug 29; 15(Pt 1):253-99. PubMed ID: 6255399
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals.
    Purtilo DT, Klein G.
    Cancer Res; 1981 Nov 29; 41(11 Pt 1):4209. PubMed ID: 6272963
    [No Abstract] [Full Text] [Related]

  • 17. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
    Sairenji T, Sullivan JL, Humphreys RE.
    J Infect Dis; 1984 May 29; 149(5):763-8. PubMed ID: 6327851
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.